You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 146 No. 9, September 1986 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Parathyroid Hypertension

A Reversible Disorder

Terrence W. Diamond, MRCP(UK); J. René Botha, FCS(SA); Jeffrey Wing, FCP(SA); Anthony M. Meyers, FCP(SA); W. John Kalk, MRCP(UK)

Arch Intern Med. 1986;146(9):1709-1712.


Abstract

• A retrospective study of 75 patients who were surgically cured of primary hyperparathyroidism from 1976 to 1984 was performed to evaluate the blood pressure and metabolic responses to parathyroid surgery. Published data on the population prevalence of hypertension (HT) in South Africa were used for comparison. The overall prevalence of HT before surgery was 47%, compared with 23% in the general population. Hypertension was most frequent in patients older than 60 years (62% vs 39% expected). Renal insufficiency was found in 13 of 35 hypertensive patients and in two of 40 normotensive patients. However, the prevalence of HT in patients with normal creatinine levels (37%) exceeded that expected. The frequency of urolithiasis and mean levels of serum and urine calcium and phosphate were similar in normotensive and hypertensive patients. Parathyroidectomy resulted in a substantial fall in both mean systolic and mean diastolic blood pressures in 54% of the hypertensive subjects, unrelated to improvement in renal function.

(Arch Intern Med 1986;146:1709-1712)



Author Affiliations

From the Endocrinology and Metabolism (Drs Diamond, Wing, and Kalk) and Renal Units (Dr Meyers), Department of Medicine and Department of Surgery (Dr Botha), Johannesburg (South Africa) Hospital. Dr Diamond is now with Royal North Shore Hospital, Sydney.


Footnotes

Accepted for publication Nov 19, 1985.

Reprint requests to Department of Medicine, Medical School, Johannesburg Hospital, York Road, Parktown, Johannesburg 2193, South Africa (Dr Kalk).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hypertensive effect of calcilytic NPS 2143 administration in rats.
Rybczynska et al.
J Endocrinol 2006;191:189-195.
ABSTRACT | FULL TEXT  

Isolation and Characterization of Coenzyme A Glutathione Disulfide as a Parathyroid-Derived Vasoconstrictive Factor
Jankowski et al.
Circulation 2000;102:2548-2552.
ABSTRACT | FULL TEXT  

Hyperparathyroidism, Hypothyroidism, and Impaired Renal Function After 10 to 20 Years of Lithium Treatment
Stancer and Forbath
Arch Intern Med 1989;149:1042-1045.
ABSTRACT  

Primary Hyperparathyroidism: A Review of the Long-term Surgical and Nonsurgical Morbidities as a Basis for a Rational Approach to Treatment
Lafferty and Hubay
Arch Intern Med 1989;149:789-796.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.